(Q53062429)

English

Expression and prognostic significance of cancer stem cell markers CD24 and CD44 in urothelial bladder cancer xenografts and patients undergoing radical cystectomy.

scientific article published on 12 March 2014

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24631171

Expression and prognostic significance of cancer stem cell markers CD24 and CD44 in urothelial bladder cancer xenografts and patients undergoing radical cystectomy. (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24631171

1 reference

based on heuristic

inferred from title

neoplastic stem cells

1 reference

based on heuristic

inferred from title

Radical cystectomy

1 reference

based on heuristic

inferred from title

10

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24631171

Martin R. Sprick

11

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24631171

author name string

Thomas Hofner

1

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24631171

Stephan Macher-Goeppinger

2

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24631171

Corinna Klein

3

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24631171

Anja Schillert

4

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24631171

Christian Eisen

5

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24631171

Steve Wagner

6

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24631171

Teresa Rigo-Watermeier

7

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24631171

Irène Baccelli

8

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24631171

Vanessa Vogel

9

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24631171

publication date

12 March 2014

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24631171

Urologic Oncology

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24631171

32

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24631171

5

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24631171

678-686

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24631171

Cancer statistics, 2013

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.01.001

7 January 2021

Stem cells, cancer, and cancer stem cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.01.001

7 January 2021

Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.01.001

7 January 2021

Cancer stem cells from colorectal cancer-derived cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.01.001

7 January 2021

CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.01.001

7 January 2021

Expression profiling of microdissected matched prostate cancer samples reveals CD166/MEMD and CD24 as new prognostic markers for patient survival.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.01.001

7 January 2021

Targeting CD24 for treatment of colorectal and pancreatic cancer by monoclonal antibodies or small interfering RNA.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.01.001

7 January 2021

Prospective identification of tumorigenic breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.01.001

7 January 2021

Identification of pancreatic cancer stem cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.01.001

7 January 2021

CD24(+) liver tumor-initiating cells drive self-renewal and tumor initiation through STAT3-mediated NANOG regulation

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.01.001

7 January 2021

CD24 expression is important in male urothelial tumorigenesis and metastasis in mice and is androgen regulated

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.01.001

7 January 2021

EpCAM is predominantly expressed in high grade and advanced stage urothelial carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.01.001

7 January 2021

Prognostic value of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and TRAIL receptors in renal cell cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.01.001

7 January 2021

Two decades' experience with a prospective biobank for urologic oncology: research, clinical care, and the patients' view

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.01.001

7 January 2021

Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.01.001

7 January 2021

Mechanisms of Disease: cancer stem cells--targeting the evil twin

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.01.001

7 January 2021

CD24 mediates rolling of breast carcinoma cells on P-selectin.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.01.001

7 January 2021

CD24 offers a therapeutic target for control of bladder cancer metastasis based on a requirement for lung colonization

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.01.001

7 January 2021

Identifiers

10.1016/J.UROLONC.2014.01.001

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24631171

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24631171

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53062429&oldid=1603780045"